Your browser doesn't support javascript.
loading
Effect of radiation therapy on patients with stage T3 or T4 malignant phyllodes tumors: a retrospective observational study based on SEER.
Zhang, Gongyin; Yang, Ping; Zeng, Jinsheng; Wei, Changlong.
Afiliación
  • Zhang G; Department of Breast Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Yang P; Department of Radiation Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Zeng J; Department of Breast Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. ndyfy01990@ncu.edu.cn.
  • Wei C; Department of Breast Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
J Cancer Res Clin Oncol ; 150(1): 2, 2023 Dec 28.
Article en En | MEDLINE | ID: mdl-38153521
ABSTRACT

PURPOSE:

Among all primary breast tumors, malignant phyllodes tumor of the breast (MPTB) make up less than 1%. In the treatment of phyllode tumors, surgical procedures such as mastectomy and breast-conserving surgery are the mainstay. MPTB has, however, been controversial when it comes to treating it with RT. We aimed to explore the prognostic impact of RT and other clinicopathologic factors on long-term survival for patients with stage T3 or T4 malignant phyllodes tumors.

METHODS:

We select patients with stage T3 or T4 MPTB who qualified for the criteria between 2000 and 2018 via the Surveillance, Epidemiology, and End Results (SEER) database. We performed 11 propensity score matching (PSM) and Kaplan-Meier analysis to explore the role of RT in long-term survival of patients with stage T3 or T4 MPTB. A univariate and multivariate analysis of breast cancer-specific survival (BCSS) and overall survival (OS) risk factors was carried out using a Cox proportional hazards model. In addition, the nomogram graph of OS and BCSS was constructed.

RESULTS:

A total of 583 patients with stage T3 or T4 malignant phyllodes tumors were included in this study, of whom 154 (26.4%) received RT, and 429 (73.6%) were treated without RT. Before adjustment, between groups with and without RT, BCSS (p = 0.1) and OS (p = 0.212) indicated no significant difference respectively. Using of PSM, the two groups still did not differ significantly in BCSS (p = 0.552) and OS (p = 0.172). In multivariate analysis, age (p < 0.001), surgery of primary site (p < 0.001) and distant metastatic status (p < 0.001) were related to prognosis, while RT still did not affect BCSS (p = 0.877) and OS (p = 0.554).

CONCLUSION:

Based on the SEER database analysis, the study suggests that the patients with stage T3 or T4 MPTB treated with RT after surgery didn't have significant differences in BCSS or OS compared to those not treated with RT.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Tumor Filoide Límite: Female / Humans Idioma: En Revista: J Cancer Res Clin Oncol / J. cancer res. clin. oncol / Journal of cancer research and clinical oncology Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Tumor Filoide Límite: Female / Humans Idioma: En Revista: J Cancer Res Clin Oncol / J. cancer res. clin. oncol / Journal of cancer research and clinical oncology Año: 2023 Tipo del documento: Article País de afiliación: China